Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 12,470 shares at $45.47 ($568K) on 2020-11-02, disclosed to the SEC on 2020-11-04.
Open-market sale of $568k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.47 | 5,698 | $259K | 45.6% |
| 2 | $45.47 | 5,698 | $259K | 45.6% |
| 3 | $46.14 | 1,074 | $50K | 8.7% |
| Total | $45.53 avg | 12,470 | $568K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |